← All stocks

Intellia Therapeutics, Inc.

NTLA Net buying

CIK 0001652130 #2130 in the set updated 18 Sep 2026

Bought (12 mo)

$1.40M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$2.17M

$371.01K on a plan · $836.38K straight out of an exercise

Sold at will

$965.81K

13 of 19 sales

Net

−$770.70K

+$436.69K against sales at will

By person

16 insiders · 21 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

LEONARD JOHN M

President and CEO

—

$1.44M (6) scheduled

−$1.44M

1,147,064

0.8186%

$14.91M

+19.5%

Cohen Fred E

Director

$1.40M (1)

—

+$1.40M

216,653

0.1546%

$2.82M

+338.1%

Dulac Edward J III

EVP, Chief Financial Officer

—

$234.19K (3)

−$234.19K

148,175

0.1057%

$1.93M

+123.4%

BASTA JAMES

EVP, General Counsel

—

$112.44K (2)

−$112.44K

156,794

0.1119%

$2.04M

+70.5%

Lebwohl David

EVP, Chief Medical Officer

—

$109.63K (1)

−$109.63K

131,192

0.0936%

$1.71M

+36.2%

Dube Michael P

VP, Chief Accounting Officer

—

$104.36K (3)

−$104.36K

66,886

0.0477%

$869.52K

+36.4%

Clark Eliana

EVP, Chief Technical Officer

—

$96.00K (2)

−$96.00K

93,864

0.0670%

$1.22M

+26.3%

Schultes Birgit C

EVP, Chief Scientific Officer

—

$78.90K (2)

−$78.90K

137,733

0.0983%

$1.79M

+98.3%

CHASE WILLIAM J

Director

—

143,893

0.1027%

$1.87M

+439.1%

Sepp-Lorenzino Laura

EVP, Chief Scientific Officer

—

77,388

0.0552%

$1.01M

−6.6%

Hicks Derek

EVP, Chief Business Officer

—

59,878

0.0427%

$778.41K

−9.8%

Keresty Georgia

Director

—

41,083

0.0293%

$534.08K

+72.0%

Bhanji Muna

Director

—

36,403

0.0260%

$473.24K

+84.5%

Verwiel Frank

Director

—

35,148

0.0251%

$456.92K

+95.8%

GOODMAN JESSE

Director

—

33,559

0.0239%

$436.27K

+72.5%

Goff Brian

Director

—

32,609

0.0233%

$423.92K

+111.6%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Dulac Edward J III

22 Jul 2026

EVP, Chief Financial Officer

Sell

8,111

$11.25

$91.25K

Dube Michael P

1 Jul 2026

VP, Chief Accounting Officer

Sell

2,641

$16.78

$44.32K

Clark Eliana

2 Mar 2026

EVP, Chief Technical Officer

Sell

607

$13.78

$8.36K

BASTA JAMES

2 Mar 2026

EVP, General Counsel

Sell

1,211

$13.78

$16.69K

Dube Michael P

5 Jan 2026

VP, Chief Accounting Officer

Sell

2,989

$9.21

$27.53K

Dulac Edward J III

5 Jan 2026

EVP, Chief Financial Officer

Sell

6,379

$9.21

$58.75K

Clark Eliana

5 Jan 2026

EVP, Chief Technical Officer

Sell

9,515

$9.21

$87.63K

Lebwohl David

5 Jan 2026

EVP, Chief Medical Officer

Sell

11,903

$9.21

$109.63K

BASTA JAMES

5 Jan 2026

EVP, General Counsel

Sell

10,397

$9.21

$95.76K

Schultes Birgit C

5 Jan 2026

EVP, Chief Scientific Officer

Sell

8,508

$9.21

$78.36K

LEONARD JOHN M

5 Jan 2026

President and CEO

Sell

34,146

$9.21

$314.48K

Dube Michael P

1 Oct 2025

VP, Chief Accounting Officer

Sell

1,871

$17.38

$32.52K

Schultes Birgit C

1 Oct 2025

EVP, Chief Scientific Officer

Sell

$17.38

$538.78

Show all 21 transactions →

What was left out

Form 4 filings counted 29

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 3

Sales straight out of an exercise 3

Sales at will 13

Transactions with no price 0

Shares from compensation/vesting 460,422

History held since 5 Jan 2017